Both primary and metastatic bronchioalveolar carcinoma cell lines H358 and H1650 showed a moderate activation of the HER1 and HER2 pathways, with H358 also exhibited a moderate activation of the c-MET and IGF-1R pathways. Here, MET is linked to lung adenocarcinoma in situ.